P/E Ratio

Transcat appoints decorated industrial leader Jaime Irick as its new CEO, signaling a strategic pivot toward accelerated growth and market expansion.

Burford Capital's leadership invests millions from their own pay, claiming shares are deeply discounted. But will the market agree with their bold move?

A new report reveals a puzzling slowdown in CLO issuance despite low credit yields. Experts analyze the hidden headwinds and shifting investor strategies.

German defense tech firm RENK Group reports a record €1.37B revenue, fueled by a 24% surge in its defense business amid global geopolitical tensions.

Backed by Nobel-winning science and French state support, Pasqal's move to go public validates the commercial promise of deep quantum technology.

Author Tom Bernard's "The Index of America" offers a roadmap to wealth via the S&P 500, arguing for disciplined strategy in a complex economic climate.

The green builder secured its Nasdaq status, but a sharp stock drop reveals market skepticism. Can its $78.5M pipeline convince cautious investors?

With major trials underway for its cancer and vision drugs, NovaBridge's upcoming investor presentation could be a pivotal moment for the biotech firm.

Manhattan's top landlord promotes Harrison Sitomer from intern to President, signaling a focus on stability as it navigates a complex office market.

As Prime Drink Group faces heavy losses, the appointment of water industry expert Germain Turpin as interim CEO signals a strategic pivot to its core assets.

Following a historic $2B revenue year, Tradeweb's CEO will address institutional investors, focusing on AI, digital assets, and global market expansion.

The waste giant is renewing its massive share repurchase program and adding a special tool to help its biggest institutional investors cash out.

Treace Medical reports a Q4 revenue dip despite surgeon growth, revealing a strategic shift to lower-priced kits and a challenging 2026 outlook.

A private market index tracking tech giants like SpaceX surged nearly 200% in 14 months, raising questions about a new, exclusive tier of wealth creation.

Apellis Pharmaceuticals reports its first profitable year on strong SYFOVRE and EMPAVELI sales, but faces pressure to maintain momentum amid competition.

With overwhelming bondholder support, the media giant gains financial flexibility for shareholder returns while tightening protections for its creditors.

The French banking giant finalizes a major capital reduction and progresses on a new buyback, signaling strong confidence and rewarding investors.

Toymaker JAKKS Pacific launches an ambitious new platform targeting the multi-billion dollar anime, manga, and creator markets. Can it beat the competition?

Upwork announces a new $300M share buyback, signaling deep confidence in its AI strategy and financial health as it aims to redefine the future of work.

With strong growth and a high valuation, BrightSpring's upcoming Investor Day is a key moment to outline its strategy for profitability and market leadership.